This was shown by the accumulation of LDs in the subventricular zone of AD models, along with evidence that cholesterol esters (CEs) within LDs contribute to tau pathology by impairing proteasome activity (Hamilton et al., 2015; Van Der Kant et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.